mRNA-LNP vaccines: rational design, delivery optimization, and clinical translation
Journal of Materials Chemistry B · 2025 · 13 (48) · 15447-15467
DOI: 10.1039/d5tb01972a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Sangni Jiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical and Biological Engineering Zhejiang University Hangzhou, Zhejiang 310058, China. 0623958@zju.edu.cn. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Lipids, COVID-19. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 154 Literaturangaben.
Abstract (Originalsprache)
This review analyzes mRNA-LNP optimization and clinical progress, highlighting novel multidisciplinary approaches for precision delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemical and Biological Engineering Zhejiang University Hangzhou, Zhejiang 310058, China. 0623958@zju.edu.cn.
- Institute of Zhejiang University, Quzhou 99 Zheda Road, Quzhou, Zhejiang 324000, China.
Zitieren
APA
Jiang, S., & Lu, Z. (2025). mRNA-LNP vaccines: rational design, delivery optimization, and clinical translation. Journal of Materials Chemistry B, 13(48), 15447-15467. https://doi.org/10.1039/d5tb01972a
Vancouver
Jiang S, Lu Z. mRNA-LNP vaccines: rational design, delivery optimization, and clinical translation. Journal of Materials Chemistry B. 2025;13(48):15447-15467. doi:10.1039/d5tb01972a
BibTeX
@article{Jiang2025,
author = {Jiang, Sangni and Lu, Zhihui},
title = {mRNA-LNP vaccines: rational design, delivery optimization, and clinical translation},
journal = {Journal of Materials Chemistry B},
year = {2025},
volume = {13},
number = {48},
pages = {15447--15467},
doi = {10.1039/d5tb01972a}
}
EUVIMED